Primary Myelofibrosis, Prefibrotic Stage
Information
- Disease name
- Primary Myelofibrosis, Prefibrotic Stage
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03869476 | Recruiting | N/A | Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. | July 30, 2019 | January 30, 2024 |
| NCT04942080 | Recruiting | N/A | Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) | October 28, 2021 | April 28, 2026 |
| NCT04988815 | Recruiting | Phase 2 | Ropeginterferon Alfa 2b for Early Myelofibrosis | September 1, 2021 | December 31, 2025 |
| NCT05882773 | Recruiting | Asian Myeloproliferative Neoplasm (MPN) Registry | May 2023 | December 2026 | |
| NCT03121599 | Terminated | N/A | 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms | June 11, 2017 | October 16, 2018 |
| NCT03116542 | Unknown status | N/A | 18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia | May 7, 2017 | August 2021 |
| NCT02528877 | Withdrawn | Phase 1 | Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis | November 2015 |